Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03525795
Title ORIOn-E: A Study Evaluating CPI-1205 in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Constellation Pharmaceuticals
Indications

melanoma

lung non-small cell carcinoma

renal cell carcinoma

transitional cell carcinoma

Advanced Solid Tumor

Therapies

CPI-1205 + Ipilimumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.